NCT01503320View on ClinicalTrials.gov

Efficacy of Enteral Glutamine Supplementation in Patients With Predicted Severe Acute Pancreatitis- A Double-Blinded Randomized Controlled Trial

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

December 31, 2014

Conditions
Acute Pancreatitis
Interventions
DIETARY_SUPPLEMENT

Enteral glutamine

Dosage of glutamine: 0.57g/kg, \~ 30g/day= 3sachets

DIETARY_SUPPLEMENT

Placebo

Similar appearing nutritional supplement without glutamine.

Trial Locations (1)

500082

Asian Institute of Gastroenterology, Hyderabad

All Listed Sponsors
lead

Asian Institute of Gastroenterology, India

OTHER

NCT01503320 - Efficacy of Enteral Glutamine Supplementation in Patients With Predicted Severe Acute Pancreatitis- A Double-Blinded Randomized Controlled Trial | Biotech Hunter | Biotech Hunter